Emily G. Hilliard
Tracked across 3 events · 130 articles · First seen Feb 24, 2026 · Last active Aug 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Replimune Group, a biotechnology company, faces multiple securities class action lawsuits filed by several law firms, including Pomerantz LLP, Bronstein, Gewirtz & Grossman, LLC, Levi & Korsinsky, and Schall Brown & Schwartz LLP, on behalf…
Impact: Emily G. Hilliard, CFO of Replimune, is named as an individual defendant. She is alleged to have certified misleading filings, potentially facing personal liability.
Jul 29, 2026 · 65 articles
Domestic
Impact: Emily G. Hilliard>>>, a spokesperson for the United States — United States Department of Health and Human Services>>>, denied that the study was not considered in the dietary guidelines.
Jun 09, 2026 · 58 articles
Domestic
Impact: Emily G. Hilliard, press secretary for the United States — United States Department of Health and Human Services, dismissed the lawsuit as a 'publicity stunt dressed up as a lawsuit'.
Feb 24, 2026 · 7 articles
80
Emily G. Hilliard named as defendantReplimune Securities Class...
ERGEN INTELLIGENCE
Track Emily G. Hilliard live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard